Clinical trials
Phase 2 Hepatitis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 4 |
| 2003 | 4 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 4 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Terminated | 4 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 9 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 6 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Arbutus Biopharma Corporation | 1 |
| AusperBio Therapeutics Inc. | 1 |
| Children's Healthcare of Atlanta | 1 |
| Conatus Pharmaceuticals Inc. | 1 |
| Debiopharm International SA | 1 |
| Dynavax Technologies Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis | 38 |
| Hepatitis C | 17 |
| Hepatitis B | 7 |
| Hepatitis B, Chronic | 7 |
| Liver Diseases | 7 |
| Fibrosis | 5 |
| Hepatitis C, Chronic | 5 |
| Hepatitis, Alcoholic | 3 |
| Hepatitis, Chronic | 3 |
| Bronchiolitis Obliterans Syndrome | 2 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.